Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

4.0K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
4.0K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

571
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
571
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

19.2K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
19.2K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

257
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
257

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping the evidence of stereotactic body radiotherapy combined with systemic therapy in oligometastatic and oligoprogressive non-small cell lung cancer: A visual synthesis of clinical outcomes and toxicity.

Cancer treatment and research communications·2026
Same author

Immunotherapy for Upper Tract Urothelial Carcinomas: A 2026 Update.

Cancers·2026
Same author

Cost-Effectiveness of Radiotherapy and Its Impact on Patient Quality of Life: A Real-World Cost Utility Analysis in Greece.

Current oncology (Toronto, Ont.)·2026
Same author

WITHDRAWN: Secondary Thyroid Cancer Risks from External Beam Radiation Exposure Modulated by Dose, Field, Sex, Age, and Latency Period

Reviews on recent clinical trials·2026
Same author

Progastrin, annexin A2, and tumor-associated macrophages in gastric adenocarcinoma.

Journal of pathology and translational medicine·2026
Same author

Radiotherapy De-Escalation in Younger Patients with Breast Cancer: Are We There Yet?

Cancers·2026

Related Experiment Video

Updated: Jan 18, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

796

Managing Erectile Dysfunction After Pelvic Radiotherapy.

Evangelos Chinis1, Vasiliki Nikovia1, Kornilia Vasiliki Orfanidou1

  • 1Medical School, University of Crete, Vassilika, 71110, Heraklion, Greece.

Reviews on Recent Clinical Trials
|September 10, 2025
PubMed
Summary
This summary is machine-generated.

Pelvic radiotherapy can cause erectile dysfunction (ED). Treatments range from oral medications to penile prostheses, with prostheses being the most effective. Further research is needed for newer therapies like stem cells.

Keywords:
Radiotherapyerectile dysfunctionneoplasmspelvistreatment

More Related Videos

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.9K
Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
02:21

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease

Published on: March 15, 2024

1.4K

Related Experiment Videos

Last Updated: Jan 18, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

796
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.9K
Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
02:21

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease

Published on: March 15, 2024

1.4K

Area of Science:

  • Oncology
  • Urology
  • Radiotherapy

Background:

  • Pelvic radiotherapy is crucial for treating pelvic cancers but often leads to permanent erectile dysfunction (ED).
  • Post-treatment ED receives limited attention, with follow-up focused on cancer recurrence.
  • This review synthesizes current treatments for radiation-induced erectile dysfunction (RIED).

Purpose of the Study:

  • To review and summarize current treatment modalities for radiation-induced erectile dysfunction (RIED).
  • To provide an overview of emerging therapies and established treatments for RIED in patients undergoing pelvic radiotherapy.

Main Methods:

  • A literature review was conducted using PubMed Central databases.
  • Searched for clinical trials on RIED management published in English from 1996 to June 2024.
  • Included all relevant studies on RIED treatment strategies.

Main Results:

  • Phosphodiesterase type 5 inhibitors (PDE5i) show short-term efficacy in maintaining erectile function (EF) post-pelvic radiotherapy.
  • Penile prostheses are highly effective but have limited application.
  • Yoga demonstrated effectiveness only in the initial 4 weeks of a specific regimen.

Conclusions:

  • Treatment options for RIED vary from oral drugs to invasive procedures, with penile prostheses offering the most definitive solution.
  • Emerging therapies like stem cell injections and platelet-rich plasma show promise but require further validation.
  • Prioritizing RIED management can significantly improve survivors' quality of life.